Two new special reports on Xconomy Insight provide an expert view on how companies can sustain clinical trials during the COVID-19 crisis. “Decentralized Clinical Trials: The Call for a New Paradigm” and “Sustaining Clinical Research During the Crisis” offer the latest trends and technologies companies can use to keep business running as smooth as possible.
Both reports are sponsored by PRA Health Sciences and feature the following:
- How incorporating virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare for patients and accelerate approval of new medications
- Remote patient monitoring strategies to mitigate risk and improve safety during the pandemic
- Access to the webinar Clinical Research and the COVID-19 Crisis